.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The management of complex infections requires a dynamic approach to address both pathogen clearance and subsequent tissue regeneration. Recently, researchers developed a programmable core-shell nanoplatform (Z-Lyc@ELP) that provides a robust strategy for sequential infection treatment. By utilizing garlic-derived exosome-like nanovesicles (GELNs), this platform adapts to the shifting pathological environment found in chronic wounds and systemic sepsis.
The Z-Lyc@ELP nanoplatform functions through a hierarchical structural separation. The outer shell contains polymyxin B and immunoregulatory molecules. When these vesicles encounter reactive oxygen species (ROS) at the site of infection, they rapidly release their cargo to remodel the pathogenic microenvironment. Furthermore, as the infection progresses and the lesion becomes more acidic, the ZIF-8 core decomposes. This second wave of intervention releases lycopene and zinc ions, which effectively scavenge excessive ROS. Consequently, this process promotes M2 macrophage polarization, upregulates angiogenic factors, and reactivates intrinsic tissue repair mechanisms.
In vivo studies demonstrate the remarkable potential of this technology. Specifically, the nanoplatform achieved a 98.1% healing rate in infectious burn wounds over 16 days. In sepsis models, the treatment resulted in an 80% survival rate over 10 days. These results highlight how pathology-guided strategies can overcome the limitations of conventional nanotechnology. Because the platform dynamically responds to environmental triggers like pH and oxidative stress, it offers a level of precision previously difficult to achieve in clinical settings.
Garlic-derived exosome-like nanovesicles offer high biocompatibility and natural responsiveness to reactive oxygen species. These traits make them ideal carriers for targeted drug delivery in inflammatory environments like infected wounds.
The core-shell structure allows for hierarchical release. The shell addresses initial pathogen invasion and immune dysfunction. Later, the core targets the recovery phase by scavenging ROS and supporting tissue regeneration as the wound environment changes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or substitute for professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Gao Y et al. Garlic-derived exosome-like nanovesicle core-shell platform for sequential infection treatment and tissue repair. J Nanobiotechnology. 2026 Feb 23. doi: 10.1186/s12951-026-04227-2. PMID: 41731513.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new Z-Lyc@ELP nanoplatform using garlic exosomes shows 98.1% healing in burn wounds and 80% sepsis survival through sequential therapeutic release....
6 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
